相似文献
1
BCG treatment of malignant pleural effusions in the rat.
Br J Cancer. 1976 Oct;34(4):368-73. doi: 10.1038/bjc.1976.179.
2
BCG therapy of pleural and peritoneal growth of transplanted rat tumours.
Int J Cancer. 1975 Feb 15;15(2):260-9. doi: 10.1002/ijc.2910150212.
3
Methanol extraction residue of BCG in the treatment of transplanted rat tumours.
Br J Cancer. 1975 Feb;31(2):176-81. doi: 10.1038/bjc.1975.23.
4
Experimental immunotherapy of neoplastic pleural effusion with oil-attached BCG cell-wall skeleton in mice.
Gan. 1976 Oct;67(5):737-40.
5
BCG and cancer (first of two parts).
N Engl J Med. 1974 Jun 20;290(25):1413-20. doi: 10.1056/NEJM197406202902506.
6
BCG immunotherapy of rat tumours in athymic nude mice.
Nature. 1975 Mar 6;254(5495):77-8. doi: 10.1038/254077a0.
7
[The study of intrapleural urokinase in the prevention of pleural thickening and loculated effusions by tuberculous pleurisy].
Zhonghua Jie He He Hu Xi Za Zhi. 2001 Jan;24(1):32-4.
8
BCG treatment of human tumour xenografts in athymic nude mice.
Br J Cancer. 1978 Dec;38(6):699-702. doi: 10.1038/bjc.1978.275.
9
C. parvum immuntherapy of transplanted rat tumours.
Int J Cancer. 1977 Dec 15;20(6):923-32. doi: 10.1002/ijc.2910200616.
10
[Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
Gan No Rinsho. 1983 Aug;29(9):955-61.
引用本文的文献
1
Malignant pleural effusion: further translational research is crucial.
Transl Lung Cancer Res. 2012 Sep;1(3):167-9. doi: 10.3978/j.issn.2218-6751.2012.09.06.
2
Manipulation of host resistance in cancer therapy.
Springer Semin Immunopathol. 1982;5(2):113-25. doi: 10.1007/BF00199791.
3
Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.
Cancer Metastasis Rev. 1983;2(1):89-106. doi: 10.1007/BF00046907.
4
Tuberculous peritonitis developing in a case of documented peritoneal carcinomatosis.
West J Med. 1985 Jul;143(1):103-5.
5
Histopathology of BCG and thiotepa treated bladders.
Urol Res. 1986;14(4):211-5. doi: 10.1007/BF00441116.
本文引用的文献
1
Vaccination against tuberculosis with nonliving vaccines. 3. Vaccination of guinea pigs with fractions of phenol-killed tubercle bacilli.
Am Rev Respir Dis. 1960 Sep;82:339-57. doi: 10.1164/arrd.1960.82.3.339.
2
BCG immunotherapy of a rat sarcoma.
Br J Cancer. 1973 Oct;28(4):281-7. doi: 10.1038/bjc.1973.149.
3
BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.
Br J Cancer. 1973 Jan;27(1):48-54. doi: 10.1038/bjc.1973.6.
4
Bacillus Calmette-Guerin in the treatment of neoplastic disease.
J Reticuloendothel Soc. 1974 Dec;16(6):347-73.
5
Use of BCG as an immunostimulant in the surgical treatment of carcinoma of the lung.
Thorax. 1974 Nov;29(6):654-8. doi: 10.1136/thx.29.6.654.
6
BCG and cancer (first of two parts).
N Engl J Med. 1974 Jun 20;290(25):1413-20. doi: 10.1056/NEJM197406202902506.
7
Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy.
J Natl Cancer Inst. 1972 Jun;48(6):1709-26.
8
Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
Int J Cancer. 1975 Oct 15;16(4):515-25. doi: 10.1002/ijc.2910160402.
9
Tumour inhibition mediated by BCG in immunosuppressed rats.
Int J Cancer. 1975 Jun 15;15(6):897-911. doi: 10.1002/ijc.2910150605.
10
Influence of whole body irradiation on bcg contact suppression of a rat sarcoma and tumour-specific immunity.
Br J Cancer. 1976 Aug;34(2):199-202. doi: 10.1038/bjc.1976.143.
Zotero 插件